The new building expands on the company’s supply chain solutions for biologics and temperature-sensitive pharmaceuticals.

The company’s mocravimod, a novel oral S1P receptor, is being evaluated for its efficacy as an addition to CAR-T cell ...

In this episode of the Ask the Expert video series, Simona Guidi, Associate Director, Cell and Gene Therapies at ProPharma, ...

Cambridge Healthcare Innovations says its dry powder inhaler engine, Quattrii, can deliver large volumes of biologic and mRNA ...

Technological advances in the design and delivery of mRNA have catalysed the rapid development of mRNA COVID-19 vaccines by ...

The department’s newly announced partnerships were part of a weeklong visit that included discussions held at BIO 2025.

The contest, which aims to accelerate the development of recombinant protein-based oncology therapies, will culminate at CPHI ...

The collaboration will focus on identifying pre-clinical candidates for high-priority targets, including a small molecule ...

By joining the network, NIBRT, Firefinch, and eg technology gain access to what EIT Health referred to as a pan-European ...

BASF announced on June 17, 2025 that it has opened a good manufacturing practice (GMP) facility in Wyandotte, Mich. as part ...

The following six biosimilars were given a positive opinion at the June meeting: treatments for treatment of age-related macular degeneration and visual impairment: Mynzepli (aflibercept), and its ...

The Commissioner’s National Priority Voucher can be used by drug developers to participate in a novel priority program for ...